| scholarly article | Q13442814 |
| P50 | author | Walter C. Willett | Q1133904 |
| Meir J. Stampfer | Q80164992 | ||
| Amy Trentham-Dietz | Q88960210 | ||
| Polly A Newcomb | Q89454622 | ||
| Linda Titus-Ernstoff | Q114301945 | ||
| P2093 | author name string | John M Hampton | |
| John A Baron | |||
| Kathleen M Egan | |||
| P2860 | cites work | Use of postmenopausal hormone replacement therapy: estimates from a nationally representative cohort study. | Q64983257 |
| The relationship between breast cancer survival and prior postmenopausal estrogen use | Q68006156 | ||
| Exogenous estrogens and development of breast and endometrial cancer | Q71139639 | ||
| Estrogen replacement therapy and risk of fatal breast cancer in a prospective cohort of postmenopausal women in the United States | Q71546196 | ||
| Carcinoma of the breast in postmenopausal hormone user and nonuser control groups | Q72398918 | ||
| Hormone replacement therapy after a diagnosis of breast cancer in relation to recurrence and mortality | Q73883089 | ||
| The impact of hormone replacement therapy on the detection and stage of breast cancer | Q74741069 | ||
| Low biologic aggressiveness in breast cancer in women using hormone replacement therapy | Q77302656 | ||
| Cardiovascular and cancer morbidity and mortality and sudden cardiac death in postmenopausal women on oestrogen replacement therapy (ERT) | Q77745893 | ||
| Lactation in relation to postmenopausal breast cancer | Q78020098 | ||
| Likelihood of additional work-up among women undergoing routine screening mammography: the impact of age, breast density, and hormone therapy use | Q80222857 | ||
| Hormone replacement therapy for breast cancer survivors: an answered question? | Q81926985 | ||
| Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial | Q27860743 | ||
| Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer | Q28142158 | ||
| Statistical methods in cancer research. Volume II--The design and analysis of cohort studies | Q29615413 | ||
| Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial | Q34208463 | ||
| Postmenopausal hormone therapy and mortality. | Q34429144 | ||
| Traditional and newer pathologic factors. | Q34482417 | ||
| Postmenopausal estrogen and progestin use in relation to breast cancer risk | Q34525017 | ||
| Influence of HRT on prognostic factors for breast cancer: a systematic review after the Women's Health Initiative trial | Q35681592 | ||
| Hormone replacement therapy and tumour grade in breast cancer: prospective study in screening unit | Q36599062 | ||
| Breast cancer with different prognostic characteristics developing in Danish women using hormone replacement therapy | Q36626131 | ||
| Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data? | Q36785763 | ||
| Mortality in a cohort of long-term users of hormone replacement therapy: an updated analysis | Q38515768 | ||
| Utility of the National Death Index for ascertainment of mortality among cancer prevention study II participants | Q40885870 | ||
| Effect of estrogen replacement therapy on the specificity and sensitivity of screening mammography | Q40985013 | ||
| Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin | Q41719517 | ||
| Relation of regimens of combined hormone replacement therapy to lobular, ductal, and other histologic types of breast carcinoma | Q43753113 | ||
| Prior to use of estrogen replacement therapy, are users healthier than nonusers? | Q43977442 | ||
| Hormone replacement therapy and breast cancer mortality in Swedish women: results after adjustment for 'healthy drug-user' effect | Q44319399 | ||
| Risks of breast and endometrial cancer after estrogen and estrogen-progestin replacement | Q44499673 | ||
| Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk | Q44507925 | ||
| Evidence of a healthy estrogen user survivor effect | Q44688183 | ||
| Survival of breast cancer patients in relation to factors which affect the risk of developing breast cancer | Q44750121 | ||
| Clinical and biologic prognostic factors in breast cancer diagnosed during postmenopausal hormone replacement therapy | Q44757087 | ||
| A prospective study of different types of hormone replacement therapy use and the risk of subsequent breast cancer: the women's health in the Lund area (WHILA) study (Sweden) | Q44923208 | ||
| Reduced mortality associated with long-term postmenopausal estrogen therapy. | Q45994980 | ||
| Breast cancer survival and hormone replacement therapy: a cohort analysis | Q46138590 | ||
| Decreased mortality in users of estrogen replacement therapy | Q46319179 | ||
| Use of postmenopausal hormone therapy since the Women's Health Initiative findings | Q46424261 | ||
| Prognostic characteristics of breast cancer among postmenopausal hormone users in a screened population | Q47351073 | ||
| Hormonal factors and breast tumor proliferation: do factors that affect cancer risk also affect tumor growth? | Q47689415 | ||
| Cancer incidence and mortality in women receiving estrogen and estrogen-progestin replacement therapy--long-term follow-up of a Swedish cohort. | Q48960509 | ||
| The role of hormone replacement therapy in the risk for breast cancer and total mortality in women with a family history of breast cancer. | Q50627109 | ||
| Prognosis after breast cancer diagnosis in women exposed to estrogen and estrogen-progestogen replacement therapy. | Q52868171 | ||
| Prognostic characteristics in breast cancers after hormone replacement therapy | Q57549479 | ||
| The Use of Estrogens and Progestins and the Risk of Breast Cancer in Postmenopausal Women | Q57752001 | ||
| Breast cancer in premenopausal women: recurrence and survival rates and relationship to hormone replacement therapy | Q60700780 | ||
| Estrogen Replacement Therapy and Breast Cancer Survival in a Large Screening Study | Q61831775 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | breast cancer | Q128581 |
| P304 | page(s) | 864-871 | |
| P577 | publication date | 2008-04-01 | |
| P1433 | published in | Cancer Epidemiology, Biomarkers & Prevention | Q326334 |
| P1476 | title | Prediagnostic use of hormone therapy and mortality after breast cancer | |
| P478 | volume | 17 |
| Q30498819 | Age-related variation in the relationship between menopausal hormone therapy and the risk of dying from breast cancer |
| Q36868621 | Alcohol consumption before and after breast cancer diagnosis: associations with survival from breast cancer, cardiovascular disease, and other causes |
| Q36903225 | Breast cancer in women using digoxin: tumor characteristics and relapse risk |
| Q35866374 | Changing concepts: Menopausal hormone therapy and breast cancer |
| Q36143058 | Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial |
| Q37480990 | Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women |
| Q34336219 | Estrogen plus progestin and breast cancer incidence and mortality in the Women's Health Initiative Observational Study |
| Q46917183 | Estrogen-progestin use and breast cancer characteristics in lean and overweight postmenopausal women |
| Q33751046 | Fatal breast cancer risk in relation to use of unopposed estrogen and combined hormone therapy |
| Q39364630 | Hormone replacement therapy and breast cancer survival: a systematic review and meta-analysis of observational studies |
| Q53115465 | Hormone therapy: rigour and responsibility in knowledge translation. |
| Q27022201 | Menopausal hormone therapy and breast cancer mortality: clinical implications |
| Q37690142 | Pre-diagnosis oophorectomy, estrogen therapy and mortality in a cohort of women diagnosed with breast cancer |
| Q89967029 | Prognostic Impact of Menopausal Hormone Therapy in Breast Cancer Differs According to Tumor Characteristics and Treatment |
| Q41065061 | Relationship between menopausal hormone therapy and mortality after breast cancer The MARIEplus study, a prospective case cohort |
| Q35050573 | Socioeconomic status and survival after an invasive breast cancer diagnosis |
| Q35268601 | Statin prescriptions and breast cancer recurrence risk: a Danish nationwide prospective cohort study |
| Q36916770 | Use of β-blockers, angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and risk of breast cancer recurrence: a Danish nationwide prospective cohort study |
Search more.